Michael Eppolito, MBA​

Senior Vice President, Research & Development Operations and Regulatory

​

​Michael Eppolito has served as our head of research & development operations and regulatory since March 2022. Mr. Eppolito supervises Eirion’s clinical and pre-clinical research operations as well as global regulatory activities. Mr. Eppolito has over 27 years of experience in clinical operations working with companies such as Octapharma USA, GlaxoSmithkline, and Teva. Mr. Eppolito holds a M.B.A in Finance from St. Joseph’s University and a B.S. in Biology from Millersville University.